How To Negotiate Executive Compensation As A Company Grows, And Other CEO Parting Pearls

A question from the audience on negotiating executive compensation during the various company growth phases is posed during this component of the executive virtual roundtable (EVR). Roger Crystal, M.D., CEO of Opiant Pharmaceuticals, discusses the importance of transparency and the use of peer groups to benchmark so there should not be any surprises when it comes to salary negotiations. This is followed by Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO of Vigil Neuroscience; Frank Lee, CEO of Forma Therapeutics; and Crystal providing parting pearls for first-time biopharma CEOs.